Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹32 Cr.
Stock P/E
27.6
P/B
0.3
Current Price
₹12.9
Book Value
₹ 44.4
Face Value
10
52W High
₹23.5
52W Low
₹ 6.7
Dividend Yield
0%

Deccan Health Care Overview

Business

Deccan Health Care Ltd. is primarily engaged in the manufacturing, marketing, and distribution of nutraceuticals, cosmeceuticals, and health supplement products. The company focuses on developing products that cater to general wellness, specific health conditions (e.g., immunity, joint health, diabetes management), and beauty care (skin and hair). Its core business model involves developing formulations, outsourcing manufacturing to third-party facilities or utilizing its own, and then marketing these products through various channels including online platforms, retail stores, and a direct selling network. The company generates revenue by selling these health and wellness products directly to consumers or through its distribution partners.

Revenue Mix

The company's revenue is primarily derived from two broad categories:

Nutraceuticals: This segment includes dietary supplements, vitamins, minerals, herbal products, and other health supplements aimed at improving overall health, immunity, energy, and managing various health conditions.

Cosmeceuticals: This segment comprises products that offer both cosmetic and medicinal benefits, such as skincare and hair care products that claim to improve specific conditions or appearance.

Specific revenue mix percentages are not readily available in public domains for this company, but both segments contribute significantly to its top line.

Industry

Deccan Health Care operates within the Indian nutraceuticals and cosmeceuticals market, which is a rapidly growing segment driven by increasing health awareness, disposable incomes, and a shift towards preventive healthcare. The market is highly fragmented and competitive, featuring a mix of large established pharmaceutical companies, fast-moving consumer goods (FMCG) giants, and numerous specialized domestic players. Deccan Health Care is a relatively small player in this competitive landscape, positioning itself with a focus on specific formulations and direct-to-consumer outreach, often through online channels and network marketing. It competes on product efficacy claims, branding, and distribution reach within its target niches.

MOAT

Deccan Health Care operates in a highly competitive market where strong, durable moats are challenging to establish for smaller players. Potential competitive advantages, though not necessarily strong moats, could include:

Formulation Expertise: Developing unique or effective combinations of ingredients for specific health needs. However, these are often replicable.

Direct Sales Network: A well-developed direct selling channel or online presence can provide a cost-effective route to market and foster customer loyalty.

Brand Recognition in Niches: Building trust and recognition for specific product lines within targeted consumer groups, though overall brand recognition remains limited compared to larger players.

True scale economies, proprietary technology, or significant switching costs are generally not present given the nature of its products and market position.

Growth Drivers

Increasing Health Awareness: Growing consumer focus on preventive healthcare, immunity boosting, and overall wellness in India.

Rising Disposable Incomes: Enhanced purchasing power among consumers leading to higher spending on health supplements and personal care.

E-commerce Penetration: Expansion of online sales channels provides wider reach and accessibility for its products.

Product Portfolio Expansion: Introduction of new and innovative nutraceutical and cosmeceutical products to cater to evolving consumer demands.

Export Opportunities: Potential to tap into international markets, particularly for herbal and natural product segments.

Risks

Intense Competition: Facing stiff competition from well-capitalized domestic and international players with larger marketing budgets and distribution networks.

Regulatory Scrutiny: Products in the nutraceutical and cosmeceutical space can be subject to evolving regulations regarding claims, labeling, and ingredient approvals, which could impact product launches or marketing strategies.

Raw Material Price Volatility: Dependency on sourcing specific raw materials whose prices can fluctuate, impacting manufacturing costs and margins.

Changing Consumer Preferences: The wellness market is dynamic, and shifts in consumer trends or perceptions can quickly render products less desirable.

Marketing Effectiveness: High reliance on effective marketing and distribution to create awareness and drive sales in a crowded market.

Management & Ownership

Deccan Health Care Ltd. is promoted by Dr. P. R. Rao (Chairman & Managing Director) and Mr. M. K. R. Prasad. Dr. Rao brings experience in the healthcare sector. As is common with SME-listed companies, promoter holding is typically significant, ensuring strong alignment with company performance. The management's focus is on expanding the product portfolio and strengthening its market presence in the health and wellness segment. Specific details on the broader management team's depth and experience or detailed governance track records are not extensively public for SME companies.

Outlook

Deccan Health Care operates in the promising and growing Indian health and wellness market, which benefits from increasing consumer health consciousness and digital adoption for product sales. This provides a favorable macro environment for product demand. However, the company faces significant challenges from intense competition, evolving regulatory landscape for health claims, and the need for continuous product innovation and effective marketing to capture market share. Its ability to build a strong brand presence, expand its distribution efficiently, and consistently introduce relevant and high-quality products will be crucial for sustainable growth in this highly competitive, fragmented sector.

Deccan Health Care Share Price

Live · BSE · Inception: 1996
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Deccan Health Care Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 17 15 16 15 19 20 21 22 21 17
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 17 15 16 15 19 20 21 22 21 17
Total Expenditure 16 14 15 14 18 20 20 21 20 16
Operating Profit 1 1 1 1 1 1 1 1 2 2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 0 0 1 0 0 0 1 1
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 1 1 0 0 1 0 0 0 1 1
Adjustments -0 0 -0 -0 0 -0 0 0 -0 0
Profit After Adjustments 1 1 0 0 1 0 0 0 1 1
Adjusted Earnings Per Share 0.3 0.3 0.1 0.2 0.3 0.1 0.1 0.1 0.4 0.4

Deccan Health Care Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 34 33 45 60 75 81
Other Income 0 0 0 0 0 0
Total Income 34 33 45 60 75 81
Total Expenditure 32 28 43 56 72 77
Operating Profit 2 6 2 4 3 6
Interest 0 0 0 0 0 0
Depreciation 1 1 1 1 1 0
Exceptional Income / Expenses 0 -3 0 0 0 0
Profit Before Tax 1 1 0 2 2 2
Provision for Tax 0 0 0 1 0 0
Profit After Tax 0 0 0 1 1 2
Adjustments 0 0 0 0 0 0
Profit After Adjustments 0 0 0 1 1 2
Adjusted Earnings Per Share 0.2 0.2 0.2 0.7 0.5 1

Deccan Health Care Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 77 77 82 97 106
Minority's Interest 0 0 0 0 0
Borrowings 1 1 1 2 1
Other Non-Current Liabilities 2 2 2 2 2
Total Current Liabilities 13 10 12 7 16
Total Liabilities 92 91 97 108 125
Fixed Assets 20 19 17 16 14
Other Non-Current Assets 6 4 4 4 4
Total Current Assets 66 68 76 88 106
Total Assets 92 91 97 108 125

Deccan Health Care Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 3 3 3 1 3
Cash Flow from Operating Activities 0 -1 -7 -13 -6
Cash Flow from Investing Activities -0 -0 0 -0 -0
Cash Flow from Financing Activities -0 0 5 14 8
Net Cash Inflow / Outflow -0 -1 -1 1 1
Closing Cash & Cash Equivalent 3 3 1 3 4

Deccan Health Care Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.25 0.21 0.18 0.73 0.49
CEPS(Rs) 1.18 1.14 1.02 1.45 1.11
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 48.76 48.97 47.86 46.9 44.94
Core EBITDA Margin(%) 6.03 16.12 4.36 6.26 4.2
EBIT Margin(%) 1.86 2.09 1.24 3.85 2.27
Pre Tax Margin(%) 1.54 1.64 0.98 3.71 2.17
PAT Margin (%) 1.15 0.97 0.68 2.5 1.54
Cash Profit Margin (%) 5.49 5.41 3.85 4.95 3.48
ROA(%) 0.42 0.35 0.33 1.46 0.99
ROE(%) 0.51 0.42 0.39 1.69 1.15
ROCE(%) 0.81 0.89 0.69 2.53 1.65
Receivable days 134.71 139.13 100.58 66.84 54.52
Inventory Days 486.07 503.31 378.03 282.48 214.7
Payable days 112.02 145.8 104.04 61.89 50.95
PER(x) 118.5 174.14 153.12 37.71 34.25
Price/Book(x) 0.6 0.73 0.57 0.59 0.38
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 1.3 1.65 1.05 0.93 0.5
EV/Core EBITDA(x) 21.03 9.84 23.72 14.75 11.81
Net Sales Growth(%) 0 -1.79 35.72 32.67 25.66
EBIT Growth(%) 0 10.73 -19.8 313.07 -25.9
PAT Growth(%) 0 -17.26 -5.11 387.62 -22.37
EPS Growth(%) 0 -17.25 -12.52 307.85 -32.48
Debt/Equity(x) 0.01 0.02 0.02 0.02 0.01
Current Ratio(x) 5.23 6.48 6.45 11.76 6.77
Quick Ratio(x) 1.69 2.05 2.47 5.67 4.05
Interest Cover(x) 5.81 4.57 4.75 26.68 22.97
Total Debt/Mcap(x) 0.02 0.02 0.03 0.03 0.03

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +25% +31%
Operating Profit CAGR -25% -21%
PAT CAGR 0%
Share Price CAGR -44% -26% -17%
ROE Average +1% +1% +1% +1%
ROCE Average +2% +2% +1% +1%

Deccan Health Care Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 19.46 %
FII 0 %
DII (MF + Insurance) 5.68 %
Public (retail) 80.54 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 16.1216.1216.1215.6618.2619.4618.4218.4218.4219.46
FII 0000000000
DII 6.536.536.536.345.875.685.375.375.375.68
Public 83.8883.8883.8884.3481.7480.5481.5881.5881.5880.54
Others 0000000000
Total 100100100100100100100100100100

Deccan Health Care Peer Comparison

Pharmaceuticals & Drugs Edit Columns

Deccan Health Care Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Deccan Health Care Pros & Cons

Pros

  • Stock is trading at 0.3 times its book value
  • Debtor days have improved from 61.89 to 50.95days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 19.46%.
  • Company has a low return on equity of 1% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp